# FDA 483 - Georgia Eye Bank, Inc. - April 30, 2026

Source: https://www.keypedia.com/records/483/georgia-eye-bank-inc/5cd7c607-1e47-422d-b6ea-cc070ee6875a

> FDA 483 for Georgia Eye Bank, Inc. on April 30, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Georgia Eye Bank, Inc.
- Inspection Date: 2026-04-30
- Product Type: biologics
- Office Name: Atlanta District Office
- Summary: An FDA inspection of Georgia Eye Bank, Inc. in Atlanta, GA, revealed a significant deficiency in its quality program. The firm failed to investigate deviations related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) and did not evaluate temperature alarms in its processing rooms. This indicates a lack of adherence to current good tissue practice (CGTP) requirements.

## Related Documents

- [483 - 2019-05-24](https://www.keypedia.com/records/483/georgia-eye-bank-inc/7cce4869-a420-4c24-a29b-86b4d75a83be)

## Related Officers

- [Jannet M. Peroti](https://www.keypedia.com/people/jannet-m-peroti/204a2444-ae5c-42dc-b4a3-f2024db3368e)
- [Steven D. Banks](https://www.keypedia.com/people/steven-d-banks/30e4d016-e386-423d-9df8-1536cf43a0a3)
- [Jennifer L. Sheehan](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/georgia-eye-bank-inc/6fb2513a-c7e5-4957-9e38-fea6c411fb9a

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7